Behind every laboratory result that reaches a clinician — whether it appears in a patient’s electronic chart seconds after testing or on a printout reviewed at the bedside — is a sophisticated digital infrastructure managing the order, the specimen, the instrument data, the quality controls, and the final report. The Laboratory Information System is that infrastructure. Understanding how it works, and how it connects to the broader clinical enterprise, is essential to understanding how modern laboratories operate safely and efficiently at scale.
What Is a Laboratory Information System and What Does It Do?
A Laboratory Information System (LIS) is a software platform that manages the complete lifecycle of a laboratory test order — from the moment a clinician places an order in the electronic health record (EHR) to the moment the verified result is delivered back to that clinician and permanently archived in the patient’s medical record. Between those two endpoints, the LIS orchestrates a complex sequence of events involving specimen accessioning, worklist management, instrument communication, quality control, result review, and result transmission.
The LIS is simultaneously the laboratory’s operational management system, its quality assurance engine, its regulatory compliance tool, and its financial record system. In large hospital laboratories processing thousands of specimens per day, the LIS is as mission-critical as the analyzers themselves — a failure of the LIS can halt laboratory operations as completely as a failure of the testing equipment.
Scale of Impact: A major academic medical center laboratory may process 5,000 to 10,000 test orders per day across chemistry, hematology, microbiology, molecular diagnostics, and other disciplines. The LIS touches every one of those orders — tracking each specimen through every step, communicating with dozens of instruments, and transmitting results to hundreds of clinical users. Its reliability and performance directly affect patient care for every one of those tests.
The Test Order Lifecycle: From Order to Report
Tracing a single molecular diagnostic test order through the LIS illustrates how many systems and steps must work in perfect coordination to deliver a reliable result.
Order Entry
Clinician enters test order in EHR; HL7 message transmitted to LIS
Accession
LIS assigns accession number; label printed with barcode for specimen tracking
Specimen Receipt
Barcode scan at check-in confirms specimen identity; demographic verification
Worklist
LIS assigns specimen to appropriate instrument worklist and transmits order
Analysis
Instrument performs test; results transmitted back to LIS automatically
QC Review
Auto-verification rules check result against QC criteria; flag for review if needed
Reporting
Verified result transmitted to EHR and delivered to ordering clinician
Bidirectional Connectivity: Instruments, LIS, and EHR
Modern laboratory operations depend on seamless bidirectional communication between the laboratory instruments, the LIS, and the hospital’s EHR. This connectivity is achieved through standardized messaging protocols — primarily HL7 (Health Level Seven) for LIS-EHR communication and ASTM or HL7 for LIS-instrument communication — that define how test orders, specimen identifiers, results, and quality control data are formatted and transmitted between systems.
Bidirectional LIS-instrument connectivity means that the LIS sends the test order to the instrument electronically when a specimen is loaded (eliminating the need for the analyst to manually enter patient demographics or test orders on the instrument), and the instrument sends results back to the LIS automatically when testing is complete. This two-way communication eliminates transcription errors, reduces the analyst workload at the instrument, and enables complete electronic audit trails that document exactly which instrument produced which result for which patient specimen at what time.
Auto-Verification: Removing the Bottleneck
In high-volume laboratories, manually reviewing every result before it is reported to the clinician would create an impossible workload and unacceptable delays. Auto-verification — rules programmed into the LIS that automatically check results against defined acceptance criteria and release them without human review when all criteria are met — resolves this bottleneck while maintaining quality.
Auto-verification rules check that results fall within analytically plausible ranges, that quality control for the relevant run met acceptance criteria, that the result is consistent with previous results for the same patient (delta check), and that no instrument flags or warning messages are associated with the result. Only results that pass all auto-verification rules are automatically reported; results that fail any criterion are flagged for manual technologist review before release. In well-designed auto-verification systems, 80 to 95 percent of results can be automatically released, with human review focused on the fraction that genuinely requires expert evaluation.
Delta Check Value: The delta check compares a patient’s current result to their most recent previous result for the same analyte. An unexpected large change — for example, an HIV viral load that jumps from undetectable to 100,000 copies/mL in two weeks — triggers a flag for review. Delta checks catch specimen identification errors, transcription errors, and clinically important result changes that require urgent clinician notification, even when the absolute result value itself falls within the analytically acceptable range.
Quality Management in the Digital Laboratory
The LIS is the central repository for all quality management data in the clinical laboratory. Internal quality control results, external proficiency testing performance, equipment maintenance records, reagent lot tracking, and corrective action documentation are all managed within or connected to the LIS, creating the comprehensive quality management record that laboratory accreditation bodies — the College of American Pathologists, CLIA, ISO 15189 — require.
QC Data Management
The LIS stores all internal QC results, applies Westgard rules or other acceptance criteria automatically, and generates QC charts that allow laboratory managers to monitor analytical performance trends over time and across reagent lots.
Reagent Lot Tracking
Every patient result is linked in the LIS to the specific reagent lots used to produce it. If a reagent lot is subsequently found to be defective, the LIS can immediately identify every patient result produced with that lot — enabling rapid, complete corrective action.
Audit Trails
Every action in the LIS — order entry, specimen receipt, result entry, result correction, report release — is permanently time-stamped and attributed to the individual user who performed it. These audit trails are legally discoverable records that may be examined in regulatory inspections, litigation, or patient safety investigations.
Proficiency Testing
External quality assessment (proficiency testing) results are tracked in the LIS, with the laboratory’s performance compared against peer laboratory benchmarks. Failures trigger mandatory corrective action documentation within the LIS quality management module.
Data Analytics and Laboratory Intelligence
The enormous volume of structured data generated by a modern clinical laboratory — instrument results, QC data, turnaround times, test volumes, reagent consumption — represents a rich resource for operational intelligence that leading laboratories are increasingly mining to drive continuous improvement. LIS-based analytics can identify turnaround time bottlenecks, optimize staffing to match testing volume patterns, predict reagent consumption to prevent stockouts, and track key performance indicators against accreditation benchmarks.
Advanced LIS platforms integrate with business intelligence tools that visualize laboratory performance data in real-time dashboards accessible to laboratory management, enabling data-driven decision-making that was impossible when performance data existed only in paper logbooks or siloed spreadsheets. These capabilities are becoming increasingly important as laboratory directors face growing pressure to demonstrate the value of laboratory services to hospital administrators who control capital and operational budgets.
Population-level analytics enabled by LIS data are also supporting infection surveillance and antimicrobial stewardship programs. Aggregate molecular diagnostic data — patterns in pathogen detection rates, emerging resistance profiles, seasonal trends in respiratory viral circulation — can be extracted from the LIS and analyzed to inform infection control decisions, antibiotic formulary reviews, and public health reporting without compromising individual patient privacy.
Essential Capabilities of a Modern Laboratory Information System
- Bidirectional HL7 connectivity with the hospital EHR for seamless order receipt and result transmission without manual data entry
- Bidirectional instrument interfaces with all laboratory analyzers enabling automatic worklist download and result upload
- Configurable auto-verification rule engine that releases routine results automatically while flagging exceptions for expert review
- Comprehensive QC management with real-time Westgard rule application, QC charting, and lot-to-lot performance tracking
- Complete specimen tracking from accession through storage and disposal with chain-of-custody documentation at every step
- Critical value alerting with escalation protocols and documentation of clinician notification for patient safety compliance
- Proficiency testing result tracking and corrective action management for accreditation compliance
- Regulatory-grade audit trails with user attribution and time stamps for every system action
- Role-based access control ensuring that only authorized personnel can view or modify specific categories of data
Cybersecurity and Data Integrity in the Lab
As laboratory systems become increasingly interconnected — with the EHR, with instrument manufacturers’ remote monitoring systems, with cloud-based analytics platforms, and with external reference laboratory networks — cybersecurity has become a critical concern for laboratory leadership. Healthcare organizations are among the most frequently targeted victims of ransomware attacks, and the LIS, with its direct connection to patient care workflows and its repository of sensitive patient health information, is a high-value target.
Laboratory information system security requires the same layered defense-in-depth approach applied to other critical healthcare IT systems: network segmentation to isolate laboratory systems from less-secure clinical networks, regular patching of operating system and application software, multi-factor authentication for user access, encrypted data transmission, and comprehensive backup and disaster recovery systems that enable rapid restoration of laboratory operations if a primary system is compromised.
Data integrity — ensuring that results stored in the LIS accurately reflect what the instrument measured and that no unauthorized modifications have occurred — is a regulatory requirement as well as a patient safety imperative. Audit trail systems that log every data change with user attribution and timestamp provide the technical foundation for data integrity assurance, and regular audit trail reviews are an expected component of laboratory quality management programs under all major accreditation frameworks.
The Invisible System That Makes Everything Possible
The Laboratory Information System rarely appears in discussions of diagnostic innovation — the excitement is directed at new molecular assays, faster instruments, and more sensitive detection methods. But without the LIS, none of those capabilities can be safely and efficiently deployed at clinical scale. It is the system that transforms raw instrument data into verified, reported, archived patient results; that enforces quality standards across millions of test results per year; and that connects the laboratory’s analytical capabilities to the clinical teams and patients who depend on them. Investing in a modern, well-integrated LIS is not a technology choice — it is a patient safety imperative.
